本頁面由Tiger Fintech (Singapore) Pte. Ltd.提供服務

Jasper Therapeutics

5.15
-0.1100-2.09%
盤後5.03-0.1200-2.33%17:46 EDT
成交量:18.57萬
成交額:95.72萬
市值:7,736.39萬
市盈率:-0.98
高:5.48
開:5.30
低:5.01
收:5.26
資料載入中...
2021/07/21

SEC問詢函

CORRESP [Cover] - Correspondence
2021/07/19

[修訂]年度報告

10-K/A [Amend] - Annual report [Section 13 and 15(d), not S-K Item 405]
2021/07/19

[修訂]季度報告

10-Q/A [Amend] - Quarterly report [Sections 13 or 15(d)]
2021/07/16

SEC問詢函

CORRESP [Cover] - Correspondence
2021/07/12

超過5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2021/06/21

企業合併公告

425 - Prospectuses and communications, business combinations
2021/06/14

企業合併公告

425 - Prospectuses and communications, business combinations
2021/06/09

企業合併公告

425 - Prospectuses and communications, business combinations
2021/06/08

企業合併公告

425 - Prospectuses and communications, business combinations
2021/06/01

企業合併公告

425 - Prospectuses and communications, business combinations
2021/05/26

企業合併公告

425 - Prospectuses and communications, business combinations
2021/05/24

[修訂]年度報告

10-K/A [Amend] - Annual report [Section 13 and 15(d), not S-K Item 405]
2021/05/24

季度報告

10-Q - Quarterly report [Sections 13 or 15(d)]
2021/05/19

企業合併公告

425 - Prospectuses and communications, business combinations
2021/05/18

重要事件披露

8-K - Current report
2021/05/07

企業合併公告

425 - Prospectuses and communications, business combinations
2021/05/07

重要事件披露

8-K - Current report
2021/05/06

企業合併公告

425 - Prospectuses and communications, business combinations
2021/05/06

重要事件披露

8-K - Current report
2021/03/30

年度報告

10-K - Annual report [Section 13 and 15(d), not S-K Item 405]